The use of fractional exhaled nitric oxide is valuable in select asthmatic patients

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose of review

Clinical management of asthma is challenging and measuring fractional exhaled nitric oxide (FeNO) can be another tool to assist in meeting this challenge.

Recent findings

Asthma is a heterogeneous condition. There are many different phenotypes. FeNO can help the physician identify which patients have eosinophilic inflammation and would potentially respond to corticosteroid therapy.

Summary

FeNO is a complement to standard asthma care. FeNO can be used in the initial diagnosis of asthma and aid in stratification of which patients would be steroid responsive but also for assessment of disease severity, response to treatment, and compliance.

Related Topics

    loading  Loading Related Articles